Cargando…
1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506461/ http://dx.doi.org/10.1016/j.annonc.2020.08.1741 |
| _version_ | 1783585023650168832 |
|---|---|
| author | Zambelli, A. Fotia, V. Bosetti, T. Negrini, G. di Croce, A. Moro, C. Poletti, P.L. Bettini, A.C. Arnoldi, E. Messina, C. Merelli, B. Callegaro, A.P. Chiudinelli, L. Mosconi, S. Tondini, C. |
| author_facet | Zambelli, A. Fotia, V. Bosetti, T. Negrini, G. di Croce, A. Moro, C. Poletti, P.L. Bettini, A.C. Arnoldi, E. Messina, C. Merelli, B. Callegaro, A.P. Chiudinelli, L. Mosconi, S. Tondini, C. |
| author_sort | Zambelli, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7506461 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75064612020-09-23 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy Zambelli, A. Fotia, V. Bosetti, T. Negrini, G. di Croce, A. Moro, C. Poletti, P.L. Bettini, A.C. Arnoldi, E. Messina, C. Merelli, B. Callegaro, A.P. Chiudinelli, L. Mosconi, S. Tondini, C. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2020-09 2020-09-22 /pmc/articles/PMC7506461/ http://dx.doi.org/10.1016/j.annonc.2020.08.1741 Text en Copyright © 2020 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Zambelli, A. Fotia, V. Bosetti, T. Negrini, G. di Croce, A. Moro, C. Poletti, P.L. Bettini, A.C. Arnoldi, E. Messina, C. Merelli, B. Callegaro, A.P. Chiudinelli, L. Mosconi, S. Tondini, C. 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title | 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title_full | 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title_fullStr | 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title_full_unstemmed | 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title_short | 1676MO Prevalence and clinical impact of asymptomatic or mildly symptomatic SARSCoV-2 infection among actively treated cancer patients during COVID-19 pandemic in Italy |
| title_sort | 1676mo prevalence and clinical impact of asymptomatic or mildly symptomatic sarscov-2 infection among actively treated cancer patients during covid-19 pandemic in italy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506461/ http://dx.doi.org/10.1016/j.annonc.2020.08.1741 |
| work_keys_str_mv | AT zambellia 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT fotiav 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT bosettit 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT negrinig 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT dicrocea 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT moroc 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT polettipl 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT bettiniac 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT arnoldie 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT messinac 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT merellib 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT callegaroap 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT chiudinellil 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT mosconis 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly AT tondinic 1676moprevalenceandclinicalimpactofasymptomaticormildlysymptomaticsarscov2infectionamongactivelytreatedcancerpatientsduringcovid19pandemicinitaly |